Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
127.4 USD | -0.07% | -2.27% | +16.64% |
May. 02 | Merck: encouraging results in gastric cancer | CF |
May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.64% | 323B | |
+30.44% | 662B | |
+21.96% | 546B | |
-5.28% | 359B | |
+4.69% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.18% | 167B | |
-2.17% | 157B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Jefferies Adjusts Merck & Company Price Target to $150 From $145